BR112012011786A2 - "método para a produção de derivados de ácido glutâmico marcados por f-18" - Google Patents

"método para a produção de derivados de ácido glutâmico marcados por f-18"

Info

Publication number
BR112012011786A2
BR112012011786A2 BR112012011786A BR112012011786A BR112012011786A2 BR 112012011786 A2 BR112012011786 A2 BR 112012011786A2 BR 112012011786 A BR112012011786 A BR 112012011786A BR 112012011786 A BR112012011786 A BR 112012011786A BR 112012011786 A2 BR112012011786 A2 BR 112012011786A2
Authority
BR
Brazil
Prior art keywords
glutamic acid
acid derivatives
production
labeled glutamic
labeled
Prior art date
Application number
BR112012011786A
Other languages
English (en)
Inventor
Hultsch Christina
Wester Hans-Jürgen
Schmitt-Willich Heribert
Graham Keith
Berndt Mathias
Friebe Matthias
Brumby Thomas
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of BR112012011786A2 publication Critical patent/BR112012011786A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)

Abstract

método para a produção de derivados de ãcido glutâmico marcados por f-18. a presente invenção refere-se a métodos, os quais proporcionam acesso a derivados de ácido glutâmico marcados f-18.
BR112012011786A 2009-11-17 2010-11-06 "método para a produção de derivados de ácido glutâmico marcados por f-18" BR112012011786A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09075508 2009-11-17
PCT/EP2010/006766 WO2011060887A2 (en) 2009-11-17 2010-11-06 Method for production of f-18 labeled glutamic acid derivatives

Publications (1)

Publication Number Publication Date
BR112012011786A2 true BR112012011786A2 (pt) 2019-09-24

Family

ID=43933363

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012011786A BR112012011786A2 (pt) 2009-11-17 2010-11-06 "método para a produção de derivados de ácido glutâmico marcados por f-18"

Country Status (15)

Country Link
US (1) US20130149243A1 (pt)
EP (1) EP2501663A2 (pt)
JP (1) JP2013510891A (pt)
KR (1) KR20120101452A (pt)
CN (1) CN102712552B (pt)
AR (1) AR080670A1 (pt)
AU (1) AU2010321278B2 (pt)
BR (1) BR112012011786A2 (pt)
CA (1) CA2780930A1 (pt)
HK (1) HK1177928A1 (pt)
IL (1) IL219698A0 (pt)
MX (1) MX2012005733A (pt)
RU (1) RU2012124810A (pt)
TW (1) TW201121572A (pt)
WO (1) WO2011060887A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107753962A (zh) 2010-12-09 2018-03-06 通用电气健康护理有限公司 放射性示踪剂组合物
EP2520557A1 (en) * 2011-05-03 2012-11-07 Bayer Pharma Aktiengesellschaft Novel precursors of glutamate derivatives
US9546193B2 (en) 2013-10-24 2017-01-17 The Regents Of The University Of California Compositions and methods for 18F-fluorodeoxyglycosylamines
CN113019279A (zh) * 2021-03-11 2021-06-25 山西医科大学第一医院 一种放射性药物制备的自动合成装置及其使用方法
WO2023229997A1 (en) * 2022-05-23 2023-11-30 Board Of Regents, The University Of Texas System Cgmp-compliant automated [18f]fspg production for clinical examination

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774243B2 (en) * 1999-08-24 2004-08-10 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
CA2421507A1 (en) * 2000-09-01 2002-03-07 Karina Aprico Screen for glutamate reuptake inhibitors, stimulators, and modulators
EP1539250A1 (en) * 2002-08-02 2005-06-15 Mallinckrodt Inc. Radioactively labelled amino acid analogues, their preparation and use
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
EP2123621A1 (de) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2086924B1 (de) * 2006-11-01 2018-09-12 Piramal Imaging SA [f-18]markierte l-glutaminsäure, [f-18]markiertes l-glutamin, ihre derivate und ihre verwendung sowie verfahren zu ihrer herstellung
EP1923382A1 (de) * 2006-11-18 2008-05-21 Bayer Schering Pharma Aktiengesellschaft [F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2123619A1 (de) * 2008-05-20 2009-11-25 Bayer Schering Pharma AG Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung
EP2123620A1 (en) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
JP2011526267A (ja) * 2008-07-03 2011-10-06 バイエル ファーマ アクチエンゲゼルシャフト 化合物および放射性医薬品の製造方法

Also Published As

Publication number Publication date
AU2010321278B2 (en) 2014-08-14
HK1177928A1 (en) 2013-08-30
WO2011060887A3 (en) 2012-04-12
CA2780930A1 (en) 2011-05-26
EP2501663A2 (en) 2012-09-26
AR080670A1 (es) 2012-05-02
KR20120101452A (ko) 2012-09-13
IL219698A0 (en) 2012-07-31
TW201121572A (en) 2011-07-01
RU2012124810A (ru) 2013-12-27
JP2013510891A (ja) 2013-03-28
CN102712552A (zh) 2012-10-03
MX2012005733A (es) 2013-01-22
CN102712552B (zh) 2015-07-22
US20130149243A1 (en) 2013-06-13
AU2010321278A1 (en) 2012-05-31
WO2011060887A8 (en) 2011-10-20
WO2011060887A2 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
BR112013002925A2 (pt) processo para a síntese de ácido 2,5-furandicarboxílico
BR112012028395A2 (pt) processo para preparar ditiina-tetracarboxi-diimidas
BR112012032244A2 (pt) processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes
BR112012024799A2 (pt) método para a produção de l-ornitina por fermentação
BRPI0807756A2 (pt) Método para produzir um l-aminoácido.
BR112012011689A2 (pt) processo para a produção de etexilato de dabigatran
BR112012000210A2 (pt) processo para a produção de heterodímeoros de ácido glutâmico.
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
BRPI1012638B8 (pt) métodos e intermediários para preparar agentes farmacêuticos
BRPI0919826A2 (pt) Micro-organismo para a producao de acido succinico.
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
BR112013019025A2 (pt) processo para o preparo de 4-amino-3-cloro-5-fluoro-6-(substituído) picolinatos
BR112013019520A2 (pt) método para produção de 2,3-butanodiol por fermentação
BRPI0817747A8 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BR112012029985A2 (pt) métodos de determinação de rotatividade beta-amiloide no sangue.
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
BR112012004482A2 (pt) "método para produzir um l-aminoácido"
BR122018074319B8 (pt) Método para preparar um composto de fórmula 14
BR112012011786A2 (pt) "método para a produção de derivados de ácido glutâmico marcados por f-18"
BR112012009292A2 (pt) processo para preparação do composto, sal de potássio, solvato de acetona, forma cristalina, e, composto
BR112012026157A2 (pt) processo para preparar ditiina-tetracarboximidas.
BR112012025490A2 (pt) ''método para produção de 1,5 oebtanodiamina''
BRPI0909695A2 (pt) processo para a preparação de nebivolol
CR20110208A (es) Proceso para la preparación de benzonorbornenos
BR112012026411A2 (pt) processo para preparar ditiina-tetracarboxi-diiminas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.